Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
Manitowoc
MTW
$888M
| $1.29M | ﹤0.01% |
60,068
+8,058
| +15% | +$142K |
2013 Q2
53 quarters
|
|
2852
Ardmore Shipping
ASC
$750M
| $1.29M | ﹤0.01% |
68,975
+5,138
| +8% | +$88.5K |
2016 Q3
40 quarters
|
|
2853
Centuri Holdings
CTRI
$2.29B
| $1.29M | ﹤0.01% |
64,125
-14,510
| -18% | -$337K |
2024 Q2
9 quarters
|
|
2854
CALL
eToro Group
ETOR
$1.83B
| $1.28M | ﹤0.01% |
50,000
| – | – |
2025 Q2
5 quarters
|
|
2855
PUT
UiPath
PATH
$6.85B
| $1.28M | ﹤0.01% |
+100,000
| New | +$1.39M |
2026 Q3
0 quarters
|
|
2856
UroGen Pharma
URGN
$1.28B
| $1.27M | ﹤0.01% |
31,294
+21,119
| +208% | +$906K |
2018 Q1
34 quarters
|
|
2857
Ovid Therapeutics
OVID
$543M
| $1.27M | ﹤0.01% |
510,623
+476,503
| +1,397% | +$1.25M |
2023 Q2
13 quarters
|
|
2858
Veeco
VECO
$2.5B
| $1.27M | ﹤0.01% |
24,492
-11,185
| -31% | -$554K |
2013 Q2
53 quarters
|
|
2859
Metallus
MTUS
$725M
| $1.27M | ﹤0.01% |
66,911
-29,095
| -30% | -$575K |
2014 Q3
48 quarters
|
|
2860
National Healthcare
NHC
$3.3B
| $1.27M | ﹤0.01% |
5,781
+3,509
| +154% | +$780K |
2016 Q1
42 quarters
|
|
2861
Chesapeake Utilities
CPK
$3.55B
| $1.27M | ﹤0.01% |
9,869
+5,626
| +133% | +$742K |
2013 Q2
53 quarters
|
|
2862
Cannae Holdings
CNNE
$732M
| $1.26M | ﹤0.01% |
82,415
+75,900
| +1,165% | +$1.15M |
2017 Q4
35 quarters
|
|
2863
Teekay Tankers
TNK
$3.09B
| $1.26M | ﹤0.01% |
13,006
+5,300
| +69% | +$447K |
2022 Q1
18 quarters
|
|
2864
Rush Street Interactive
RSI
$1.41B
| $1.26M | ﹤0.01% |
62,037
+17,366
| +39% | +$473K |
2022 Q1
18 quarters
|
|
2865
Beta Bionics
BBNX
$968M
| $1.26M | ﹤0.01% |
66,346
+51,410
| +344% | +$923K |
2025 Q1
6 quarters
|
|
2866
Northwest Natural Holdings
NWN
$2.19B
| $1.26M | ﹤0.01% |
26,970
+9,407
| +54% | +$467K |
2013 Q2
53 quarters
|
|
2867
Ingevity
NGVT
$2.14B
| $1.26M | ﹤0.01% |
17,777
+9,591
| +117% | +$692K |
2016 Q2
41 quarters
|
|
2868
HUB Group
HUBG
$1.49B
| $1.25M | ﹤0.01% |
42,403
+13,603
| +47% | +$561K |
2016 Q1
42 quarters
|
|
2869
CALL
Five Below
FIVE
$13.8B
| $1.25M | ﹤0.01% |
+5,700
| New | +$1.28M |
2026 Q3
0 quarters
|
|
|
2870
PUT
Five Below
FIVE
$13.8B
| $1.25M | ﹤0.01% |
+5,700
| New | +$1.28M |
2026 Q3
0 quarters
|
|
2871
CALL
Churchill Downs
CHDN
$6.9B
| $1.25M | ﹤0.01% |
16,500
-22,400
| -58% | -$1.92M |
2026 Q2
1 quarter
|
|
2872
OFG Bancorp
OFG
$2.14B
| $1.24M | ﹤0.01% |
24,817
+12,885
| +108% | +$669K |
2013 Q2
53 quarters
|
|
2873
CALL
GFL Environmental
GFL
$18.9B
| $1.24M | ﹤0.01% |
+29,700
| New | +$1.22M |
2026 Q3
0 quarters
|
|
2874
Vista Energy
VIST
$6.19B
| $1.24M | ﹤0.01% |
18,962
-878
| -4% | -$60.3K |
2024 Q4
7 quarters
|
|
2875
OppFi
OPFI
$507M
| $1.24M | ﹤0.01% |
205,087
+138,203
| +207% | +$1.11M |
2022 Q2
17 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.